• Anticoagulants are essential to prevent clotting during apheresis, which uses extracorporeal circuits.

  • When choosing an anticoagulant, one should consider the type of apheresis, the materials used (such as in the adsorption column and filter), and the patient’s bleeding risk.

  • Adequate monitoring of clotting function in patients is important for a safe and smooth apheresis procedure.


Activate Charcoal Fresh Freeze Plasma Activate Partial Thromboplastin Time Activate Clotting Time Extracorporeal Circuit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Akizawa T (1996) Kesshojokakizai to kogyokozai no tsukaiwake. In: Agishi T (ed) Kesshojokaryoho. Igaku shoin, Tokyo, pp 134–139Google Scholar
  2. 2.
    Amemiya H (2007) Jpn J Apher 26:89–92Google Scholar
  3. 3.
    Kanamori N et al (1990) Yakuri Chiryo 18:2187–2197Google Scholar
  4. 4.
    Kobayashi C (1995) Jpn J Apher 14:474–479Google Scholar
  5. 5.
    Shinoda T (1999) Jpn J Apher 18:136–137Google Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  1. 1.Department of Nephrology & Endocrinology, School of MedicineThe University of TokyoTokyoJapan
  2. 2.Department of Hemodialysis & ApheresisUniversity Hospital, The University of TokyoTokyoJapan

Personalised recommendations